产品名称 IDO2 Antibody from ROCKLAND IMMUNOCHEMICALS INC.
产品货号 600-401-C69
产品价格 现货询价,电话:010-67529703
产品规格 100 µg
产品品牌 ROCKLAND IMMUNOCHEMICALS INC.
产品概述
产品详情
Edit&nbsp
Antigenic SpecificityIDO2
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse
Isotypen/a
Formataffinity purified
Size100 µg
Concentration100ug/ml
ApplicationsELISA, IF Microscopy, Immunoprecipitation, Western Blot. Anti-IDO2 antibody has been tested for use in ELISA, IF, and Western Blotting. Specific conditions for reactivity should be optimized by the end user. Expect a band approximately 45.4 kDa in size corresponding to IDO2 protein by western blotting in the appropriate cell lysate or extract. IHC testing has been negative.
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-IDO2 antibody is directed against IDO2 protein. The rabbit polyclonal antibody was affinity purified against the antigen. Prior to affinity purification the antibody was pre-cleared of any cross reactive antibody to IDO1 (human and mouse). A BLAST analysis was used to suggest cross-reactivity with IDO2 protein from human and mouse 100% based on homology with the immunizing sequence. Reactivity against homologues from other sources is not known.
ImmunogenIDO2 antibody was prepared from whole rabbit serum produced by repeated immunizations with a mixture of human and mouse full length protein corresponding to IDO2.
Other Namesrabbit anti-IDO2 antibody, IDO 2, IDO-2, Indoleamine 2,3-dioxygenase 2, Indoleamine 2,3-dioxygenase-like protein 1, INDOL1, Indoleamine-pyrrole 2,3-dioxygenase-like protein 1
Gene, Accession #IDO2, Gene ID: 169355, NCBI: NP_919270.2, UniProt: Q6ZQW0
Catalog #600-401-C69
Price
Order / More InfoIDO2 Antibody from ROCKLAND IMMUNOCHEMICALS INC.
Product Specific ReferencesMetz, R., DuHadaway, J., Rust, S., Muller, A. and Prendergast, G. (2010) The Antitumor Properties of Zinc Protoporphyrin IX, a Heme Oxygenase-1 Inhibitor, Is Dependent in Part on Functional IDO1. MolCancer Ther. Jun; 9(6):1864-71.
产品资料